Search results
Here's Why Novartis (NVS) is a Strong Value Stock
Zacks via Yahoo News· 1 month agoTaking full advantage of the stock market and investing with confidence are common goals for new and old investors alike. While you may have an investing...
Novartis (NVS) Reports Positive Long-Term Data on CSU Drug
Zacks via Yahoo News· 2 months agoNovartis NVS announced new long-term efficacy and safety data from the late-stage studies REMIX-1...
Exploring Analyst Estimates for Novartis (NVS) Q1 Earnings, Beyond Revenue and EPS
Zacks via Yahoo News· 3 months agoEvaluate the expected performance of Novartis (NVS) for the quarter ended March 2024, looking beyond...
Compared to Estimates, Novartis (NVS) Q1 Earnings: A Look at Key Metrics
Zacks via Yahoo News· 3 months agoThe headline numbers for Novartis (NVS) give insight into how the company performed in the quarter...
Drugmakers in Medicare negotiations spent more on shareholder payments and marketing than R&D last...
The Hill via Yahoo News· 3 months agoA new report from the center-left watchdog group Accountable US found that most major drugmakers...
Novartis (NVS) Presents Positive Data on Rare Kidney Disease Drug
Zacks via Yahoo News· 3 months agoNovartis (NVS) announces encouraging data on Fabhalta from a phase III study for the treatment for...
Top Research Reports for Novartis, Amgen & Palo Alto Networks
Zacks via Yahoo News· 6 months agoToday's Research Daily features new research reports on 16 major stocks, including Novartis AG...
Top Analyst Reports for Novartis, American Express & ConocoPhillips
Zacks via Yahoo News· 3 months agoToday's Research Daily features new research reports on 16 major stocks, including Novartis AG...
Exclusive-Novartis in the lead to acquire cancer drug developer MorphoSys-sources
Reuters via Yahoo News· 6 months ago(Reuters) -Drug maker Novartis AG is in advanced talks to acquire MorphoSys AG, a developer of...
Voyager (VYGR) Gains on Gene Therapy Deal With Novartis
Zacks via Yahoo News· 7 months agoVoyager (VYGR) enters into a capsid license agreement with Novartis for Huntington's disease and...